Facetten
Zugriff
Einrichtung
Medientyp
- Text 5
Karte
Erscheinungsjahr
Autor/in
- Oriol, Albert
- Weisel, Katja 3
- Facon, Thierry 2
- Lonial, Sagar 2
- Richardson, Paul G 2
- alle zeigen
Sprache
- Englisch 5
5 Einträge gefunden
-
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial
- Lonial, Sagar
- Popat, Rakesh
- Hulin, Cyrille
- Jagannath, Sundar
- Oriol, Albert
- Richardson, Paul G
- Facon, Thierry
-
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
- Munshi, Nikhil C
- Anderson, Larry D
- Shah, Nina
- Madduri, Deepu
- Berdeja, Jesús
- Lonial, Sagar
- Raje, Noopur
-
Carfilzomib and dexamethasone versus eight cycles of bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma: an indirect comparison using data from the phase 3 ENDEAVOR and CASTOR trials
- Weisel, Katja
- Majer, Istvan
- DeCosta, Lucy
- Oriol, Albert
- Goldschmidt, Hartmut
- Ludwig, Heinz
- Campioni, Marco
-
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
- Richardson, Paul G
- Oriol, Albert
- Beksac, Meral
- Liberati, Anna Marina
- Galli, Monica
- Schjesvold, Fredrik
- Lindsay, Jindriska
-
Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients
- Xicoy, Blanca
- Ribera, Josep-Maria
- Müller, Markus
- García, Olga
- Hoffmann, Christian
- Oriol, Albert
- Hentrich, Marcus